C

The available evidence indicates that fondaparinux’s usefulness as a routine peri-operative bridging agent is not yet established; while it may be considered in select situations (e.g., heparin-induced thrombocytopenia), current data are insufficient for a definitive recommendation [Garwood, 2011, PMID 21164063].